Search Results

Hay on class B GPCRs, RAMPs, and the selectivity problem in CGRP-targeted migraine therapies - what the approved drugs may still be getting wrong. << Back to podcast list Strategic Partner(s) Debbie Hay: ABOUT THE GUEST Hay is a professor of pharmacology at the University of Otago, New Zealand. Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University Debbie Hay on the web LinkedIn Wikipedia University of Otago University of Auckland Google Scholar Pubmed

Debbie Hay , University of Otago. Feb 2021 — Episode #27 released featuring Dr. Robert J.

Debbie Hay, Dr. Randy Hall, tributes toDr. Marc Caronwith over 30 guests includingDr.

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

forms, specifically the short and long forms of the stimulatory G protein, Galpha-s(s) and Galpha-s(l) We demonstrated that Galpha-s(l), but not Galpha-s(s), regulates extracellularly regulated kinases (ERK We speculate that these aberrations in Galpha-s(l), specifically, may be involved in other pathologies

In particular, she is looking at L- and D-lactate-activated HCAR1 signaling.

Caron, Ph.D. is the Frederik L.

Caron, Ph.D. is the Frederik L.

Sherbrooke's industry-integrated curriculum and what it modeled about flexibility 26:06 Surviving crisis in Haiti Sciences, des Technologies et des Etudes Avancées d’Haïti (ISTEAH) to help consolidate higher education in Haiti on the web Website LinkedIn Researchgate Loop Academia Pubmed Adhesion GPCR Consortium University of Haiti